Noriyuki Katsumata - Concepedia

Author

Noriyuki Katsumata

National Center For Child Health and Development ORCID

Also Known As

Katsumata N., N KATSUMATA, N Katsumata, N. KATSUMATA, N. Katsumata, NORIYUKI KATSUMATA, Noriyuki KATSUMATA, Noriyuki Katsumata

122

Publications

2.8K

Citations

H-Index

108

Concepts

All Affiliations

National Center For Child Health and Development Kanagawa Children's Medical Center Tohoku University Gunma University Keio University

About

Noriyuki Katsumata is an author at National Center For Child Health and Development specializing in medicine, endocrinology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	33	1.5K
2	Public Health	5	5	313
3	Engineering	4	4	58
4	Natural Sciences	4	4	156
5	Education	2	2	32

Noriyuki Katsumata

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7 Satoshi Narumi, Naoko Amano, Tomohiro Ishii, Nature Genetics Mendelian DisorderGenetic DisorderMirage SyndromeGeneticsSamd9 Mutations	2016	321
Clinical Assessment and Mutation Analysis of Kallmann Syndrome 1 (<i>KAL1</i>) and Fibroblast Growth Factor Receptor 1 (<i>FGFR1</i>, or<i>KAL2</i>) in Five Families and 18 Sporadic Patients Naoko Sato, Noriyuki Katsumata, Masayo Kagami, The Journal of Clinical Endocrinology & Metabolism	2004	219
Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method Tsuyoshi Isojima, Akira Shimatsu, Susumu Yokoya, Endocrine Journal NutritionCentile CurvesIgf-i ConcentrationsMetabolic DisorderHuman Growth	2012	205
Compound Heterozygous Mutations in the Cholesterol Side-Chain Cleavage Enzyme Gene (<i>CYP11A</i>) Cause Congenital Adrenal Insufficiency in Humans Noriyuki Katsumata, Masatoshi Ohtake, Toru Hojo, The Journal of Clinical Endocrinology & Metabolism	2002	116
Expression of insulin-like growth factor 1 receptor in primary breast cancer: Immunohistochemical analysis Chikako Shimizu, Tadashi Hasegawa, Yoichi Tani, Human Pathology Breast OncologyGrowth HormoneCancer GrowthPrimary Breast CancerBreast Cancer	2004	109
Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. Mark B. Zimering, Noriyuki Katsumata, Yuji Sato, The Journal of Clinical Endocrinology & Metabolism Human GrowthImmunologyPathologyAnterior PituitaryTumor Biology	1993	101
Mastermind-like Domain-containing 1 (MAMLD1 or CXorf6) Transactivates the Hes3 Promoter, Augments Testosterone Production, and Contains the SF1 Target Sequence Maki Fukami, Yuka Wada, Michiyo Okada, Journal of Biological Chemistry GeneticsGenomic MechanismMolecular BiologyEpigeneticsTranscriptional Regulation	2007	86
Circulating Fibroblast Growth Factor-Like Substance in Familial Multiple Endocrine Neoplasia Type 1* Mark B. Zimering, Maria Luisa Brandi, Donald A. de Grange, The Journal of Clinical Endocrinology & Metabolism	1990	72
Homozygous Mutation of P450 Side-Chain Cleavage Enzyme Gene (CYP11A1) in 46, XY Patient with Adrenal Insufficiency, Complete Sex Reversal, and Agenesis of Corpus Callosum Hessa al Kandari, Noriyuki Katsumata, Suzan Alexander, The Journal of Clinical Endocrinology & Metabolism	2006	66
HER2 Is Frequently Over‐expressed in Ovarian Clear Cell Adenocarcinoma: Possible Novel Treatment Modality Using Recombinant Monoclonal Antibody against HER2, Trastuzumab Masaki Fujimura, Noriyuki Katsumata, Hiroshi Tsuda, Japanese Journal of Cancer Research Ovarian Endometrioid AdenocarcinomaMedicineNormal Mammary GlandImmunologyPathology	2002	61

Page 1